BETRF Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 18:47):

BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally...

Stats
Dzisiejszy wolumen	94 115.00
Średni wolumen	26 624.00
Kapitalizacja rynkowa	10.24M
EPS	$0 ( 2024-01-02 )
Następna data zysków	( $0 ) 2024-06-26
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.00
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2014-01-31	Doroudian Ahmad	Sell	0	Common Shares
2014-01-31	Doroudian Ahmad	Buy	0	Common Shares
2011-01-31	Doroudian Ahmad	Sell	0	Common Shares
2011-01-31	Doroudian Ahmad	Buy	0	Common Shares
2010-05-25	Doroudian Ahmad	Buy	800 000	Stock Options

INSIDER POWER
0.00
Last 6 transactions
Buy: 1 300 000 \| Sell: 0

BetterLife Pharma Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BetterLife Pharma Inc. Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-18 435.00 (0.00 %)
EPS:	$-0.100

FY	2023
Przychody:	$0
Zysk brutto:	$-18 435.00 (0.00 %)
EPS:	$-0.100

FY	2022
Przychody:	$26.93B
Zysk brutto:	$26.93B (100.00 %)
EPS:	$-0.160

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.340

Financial Reports:

No articles found.

BetterLife Pharma Inc.

BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's pipeline products include BETR-001 for the treatment of major depressive disorder, treatment resistance depression, cluster headaches, and post-traumatic stress disorder; and BETR-002 to treat benzodiazepine dependency, anxiety, and spasticity. It is also developing MM-003 for treatment of COVID-19 and other respiratory viral infections; MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and AP-002 for the treatment of cancer. BetterLife Pharma Inc. has a research agreement with the University of California San Diego for preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.